O nce thought to be rare in the pediatric population, allergic contact dermatitis (ACD) is now recognized as a significant problem (Fernandez Vozmediano, Armario & Hita, 2005; Lewis, Statham, & Chowdhury, 2004; Seidenari, Giusti, Pepe, & Montovani, 2005) . Rates of ACD in children are on the rise (Beattie, Green, Lowe, & LewisJones, 2007; Jacob, Brod, & Crawford, 2008) , perhaps due to increased exposure to sensitizing agents early in life (Militello, Jacob, & Crawford, 2006) . Frequently listed among the most potent sensitizing agents are the preservatives and formaldehydes present in many everyday items (Hogeling & Pratt, 2008; Pratt et al., 2004; Zug et al., 2008) , including cosmetics, baby products, and topical antibiotics. In fact, formaldehyde is an extremely sensitizing agent and has been reported to evoke positive patch-test reactions at concentrations as low as 30 ppm (Jordan, Sherman, & King, 1979) . The ubiquity of the formaldehyde-releasing preservatives (FRPs) is partially because they are inexpensive compounds which can be added to products to inhibit the growth of microorganisms by slowly releasing formaldehyde over time. This extended-time-release feature allows the concentration of free formaldehyde contained in the products to remain low and theoretically lowers the risk of contact allergy (Sasseville, 2008) . Nevertheless, many patients continue to develop allergy to formaldehyde and the FRPs Pratt et al., 2004) .
QUATERNIUM-15
Repeatedly, the most sensitizing of these, quaternium-15 (Q15), has been shown to be a strong allergen (Hogeling & Pratt, 2008; Marks, Belsito, & DeLeo, 2000; Pratt et al., 2004; Zug et al., 2008) . At a concentration of 0.1%, Q15 releases 100 ppm of free formaldehydeVan amount that is well within the range to evoke an allergic response (Herbert & Rietschel, 2004) . The North American Contact Dermatitis Group (NACDG) found that 9.3% of the 4,910 patients patch tested between 2001 and 2002 had relevant reactions to Q15 (Pratt et al., 2004) . Even more concerning, the sensitization rates in children are also high (Hogeling & Pratt, 2008; Zug et al., 2008) . Zug et al. (2008) found that 3.6% of 0-to 18-year-olds referred for patch testing had clinically relevant reactions to Q15, placing it among the Top 6 allergens in this age group. This is not surprising given the fact that this product is contained in many baby products and potentially transferred caregiver cosmetics, and early age of contact with any compound is a known risk factor for sensitization later in life (Onder & Adisen, 2008; Nijhawan, 2009) . Furthermore, Q15 has been determined by the NACDG to be even more sensitizing than formaldehyde (Pratt et al., 2004) . In addition, it is present in an alarmingly high number of baby products, making exposure and potential sensitization at an early age increasingly common. In the recently released NACDG pediatric article, Q15 was shown to have sensitized 7% of the children younger than 5 years (Zug et al., 2008) . Table 1 lists many commonly used products that contain Q15. Table 2 lists the names of other FRPs and their rates of sensitization as reported by the NACDG.
CONCLUSION
All children presenting with recalcitrant dermatitis or with dermatitis in atypical areas, such as eyelid or hand Pratt et al. (2004) . aqs = aqueous; pet = petrolatum; DMDM = 1, 2-dimethylol-5, 5-dimethyl.
PATIENT SAFETY VOLUME 1 | NUMBER 3 | MAY/JUNE 2009 eczema, should be referred for patch testing. Should the child react to Q15 (or any other allergen), a list of products used at home should be obtained and avoidance should be implemented. There are a number of alternative preservatives that are less allergenic that may suitable to take the place of Q15 and the other FRPs. Patient and parental education regarding the sources of exposure is paramount as avoidance may result in prevention of sensitization or an improvement in the child's existing dermatitis .
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